INTRODUCTION
Septic or endotoxic shock results in a biphasic response in terms of hepatic carbohydrate metabolism, with an initial hyperglycaemia followed by a profound hypoglycaemic phase [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] . The latter response can be mimicked by treatment of rats with bacterial endotoxins, which results in a 40-50 % inhibition of hepatic gluconeogenesis in subsequently isolated hepatocytes. Although this has been established for many years, the mechanisms underlying this response have not been elucidated. One of the major features of endotoxic shock is the induction of nitric oxide synthase in the liver [11] [12] [13] [14] [15] , and we have recently shown that NO itself is capable of inhibiting hepatic gluconeogenesis at physiological concentrations [16, 17] . Incubation of hepatocytes with the artificial NO donors S-nitroso-N-acetylpenicillamine, 3-morpholinosydnonimine or S-nitrosoglutathione results in a reversible dose-and time-dependent inhibition of glucose synthesis. In addition, they result in a similar pattern of inhibition of glucose synthesis from a variety of substrates to that exhibited following endotoxin treatment of the rat [16, 17] . Similarly, the inhibition of glucose synthesis by endotoxin shows a comparable time of onset to the induction of NO synthase in the liver [17] .
Numerous studies have implicated changes in the circulating concentrations of a number of cytokines, including tumour necrosis factor-α (TNF-α), interleukin-1β (IL-1β) and interferon-γ (IFN-γ), in the pathophysiology of endotoxic shock (reviewed in [18] ). The work of Curran et al. [14] has indicated that the induction of NO synthase by bacterial endotoxin in i o can be mimicked by treating cultured hepatocytes with a combination of lipopolysaccharide (LPS) and this mixture of cytokines. Further work by Stadler et al. [19] has indicated that this combination of cytokines can inhibit glucagon-stimulated glucose production in cultured hepatocytes, although there was no significant effect on the control rates of glucose production. This inhibition was correlated with the production of NO, as judged * To whom correspondence should be addressed.
inhibition of gluconeogenesis observed in endotoxic shock. The maximal inhibition of glucose output required the presence of all the cytokines plus lipopolysaccharide, whereas the induction of NO synthase was independent of the lipopolysaccharide when the cytokines were employed. Inclusion of interferon-γ was essential to obtain a maximal response for either parameter. Inclusion of 1 mM N G -monomethyl--arginine in the incubation abolished the increase in NO # − jNO $ − observed with the complete cytokine mixture and various combinations ; however, it failed to prevent the inhibition in glucose output, indicating that mechanisms other than NO underlie the cytokine-induced inhibition of glucose release.
by the production of nitrite, and could be inhibited by the inclusion in the medium of N G -monomethyl--arginine (-NMMA), an inhibitor of NO synthase, indicating the involvement of NO.
The aims of this study were, first, to confirm that LPS plus multiple cytokines is capable of inhibiting glucose synthesis in hepatocytes and, secondly, to characterize this inhibition in terms of site of action, cytokine specificity and involvement of NO.
EXPERIMENTAL Materials
Williams' Medium E, LPS (a trichloroacetic acid extract from Salmonella typhimurium), antibiotics and collagenase were obtained from Sigma Chemical Co. (Poole, Dorset, U.K.). Low-tryptophan minimal essential medium, glucose-and amino acid-free minimal essential medium, newborn calf serum and recombinant rat IFN-γ were obtained from Life Technologies Ltd. (Paisley, Renfrewshire, Scotland, U.K.). Recombinant human TNF-α was obtained from Calbiochem Novabiochem (U.K.) Ltd. (Nottingham, U.K.). Recombinant human IL-1β was a gift from Dr. D. Schulster (N.I.B.S.C., South Mimms, Herts., U.K.). All other reagents were from Sigma or BDH Laboratory Supplies (Poole, Dorset, U.K.).
Preparation and culture of hepatocytes
Male Sprague-Dawley rats (180-220 g body wt.) were starved for 18 h and hepatocytes prepared as described previously [9] . The hepatocytes were resuspended to a final concentration of 1.1i10& cells\ml in Williams' Medium E supplemented with 25 mM Hepes, pH 7.4, 2 mM glutamine, 5 % (v\v) heat-inactivated neonatal calf serum, 10& units\l penicillin, 100 mg\l streptomycin, 1 µM insulin and 0.1 µM dexamethasone. A 1 ml sample of cells was plated in a collagen-coated 24-well dish to give a cell density of 56 000 cells\cm#. Preliminary studies indicated that this cell density was optimal for obtaining maximal rates of gluconeogenesis. The expression of NO synthase activity is also known to be cell-density-dependent and optimal at this cell concentration [20] . Although dexamethasone is known to prevent the induction of NO synthase activity in liver [21, 22] , preliminary experiments showed it to be essential for maintaining maximal rates of glucose output, the rate being increased by 60 % in the presence of 0.1 µM dexamethasone. The percentage inhibition of glucose production by the complete cytokine mixture was not changed significantly by the presence of the steroid (32 % versus 38 %) and therefore it was included throughout the plating and treatment period with cytokines. After 24 h the medium was replaced with 0.5 ml of medium without insulin and the cells treated for the appropriate time in the presence or absence of cytokines plus LPS. The cytokines and LPS were added at the following final concentrations : IFN-γ, 100 units\ml ; TNF-α, 500 units\ml ; IL-1β, 100 units\ml ; LPS, 10 µg\ml. When different time periods of treatment with the cytokines were used, the total time of culture of the cells was kept constant to ensure that the rates of glucose synthesis remained unaltered. At the end of the cytokine treatment period, the medium was removed and retained for the determination of NO # − jNO $ − , and replaced with 0.5 ml of a modified minimal essential medium containing no glucose, penicillin or streptomycin, but with 10 µM tryptophan, 25 mM Hepes, pH 7.4, and 10 mM lactate plus 1.0 mM pyruvate. After a further 2 h incubation period, the medium was removed and deproteinized by the addition 0.1 vol. of 2.7 M HClO % for the determination of glucose output, and the cell protein was solubilized in 0.1 M NaOH.
When the effects of different substrates were to be determined, the final cell incubation medium consisted of a glucose-and amino acid-free minimal essential medium containing the appropriate gluconeogenic substrates. Glucose output was measured in the deproteinized\neutralized medium with a fluorimetric assay using hexokinase [23] .
NO synthase activity in the cells was estimated by measuring the production of NO # − jNO $ − in the Williams' medium (arginine concentration 0.29 mM) during the 24 h treatment period with cytokines. NO # − jNO $ − was assayed using the Griess reagent following conversion of the NO $ − into NO # − using metallic cadmium [16] . The assay was not sufficiently sensitive to measure NO production in the final cell incubations used to determine glucose production. Protein was measured by the method of Lowry et al. [24] .
Statistics
Results were calculated from triplicate observations within each experiment and are expressed as meanspS.E.M., with the numbers of individual cell preparations indicated. The level of significance of differences between the means was calculated using analysis of variance. Table 1 shows the effect of treatment of hepatocytes with a combination of cytokines plus LPS known to induce NO synthase activity in cultured hepatocytes [14, 19] . In agreement with previous studies, this combination significantly increased NO production as measured by NO # − jNO $ − output over the 24 h incubation period in the presence of the cytokines, the magnitude of the increase being 9.3-fold. The presence of the cytokines also significantly decreased the rate of glucose output by the cells (40 %) during the subsequent 2 h cell incubation. This decrease is comparable in magnitude to that observed following either endotoxin treatment of the intact animal or treatment of isolated hepatocytes with artificial NO donors [7] [8] [9] [10] 16, 17] . This confirms the recent report by Stadler et al. [19] that this combination of cytokines is capable of inhibiting glucose synthesis, although in the present study the basal rate of glucose synthesis was inhibited, more closely mimicking the effect of endotoxin action in i o. The difference between the two studies may reflect the fact that the basal rates of gluconeogenesis are much higher in the present study, the rate being sustained by the maintenance of phosphoenolpyruvate carboxykinase activity by the presence of dexamethasone throughout and the use of a medium low in tryptophan to prevent the well documented inhibition of phosphoenolpyruvate carboxykinase by tryptophan and its metabolites [25] . Table 2 shows the effects of cytokine treatment of the cells on glucose output in both the absence and the presence of a variety of gluconeogenic precursors. Glucose output was significantly lowered in cells incubated in the absence of substrate, suggesting The experimental protocol was as described in Table 1 , except that the cytokines were added in different combinations. Glucose output and NO 2 − jNO 3 − formation were measured over 2 h and 24 h respectively. Abbreviations used : T, TNF-α ; L, LPS ; I, IL-1β ; F, IFN-γ. Significance of differences compared with control : *P 0.05 ; **P 0.01 ; ***P 0.001. that the cytokine treatment also inhibited the rate of glycogenolysis in these cells. The rate of glycogenolysis was 24 % and 26 % of the rate of total glucose release measured in the presence of lactate plus pyruvate in the control and cytokine-treated cells respectively, suggesting either a common mechanism of inhibition of both gluconeogenesis and glycogenolysis or non-specific cell damage following cytokine addition. However, cytokine treatment of the cells had no significant effect on the release of lactate dehydrogenase (results not shown), suggesting that this is a specific effect on glucose output rather than non-specific cell damage. Total glucose release was inhibited by the presence of the cytokines with all substrates that enter the pathway below the level of triose phosphates, the magnitude of the inhibition being comparable for all substrates. In contrast, glucose output in the presence of dihydroxyacetone was not significantly altered following cytokine treatment of the cells, further supporting the conclusion that the cytokines were not causing their effect by non-specific cell damage. Similar results were obtained with glycerol as the substrate (results not shown). These results compare favourably with previous reports investigating the site of action of endotoxin treatment of the rat [7] and also the in itro effects of NO donors [16] . Taken together, these results suggest that this combination of cytokines also inhibits the gluconeogenic pathway at the level of phosphoenolpyruvate carboxykinase, and that these cytokines may underlie the inhibition of glucose synthesis in endotoxic shock.
RESULTS AND DISCUSSION

Effect of a combination of multiple cytokines plus LPS on glucose output
Requirement for individual cytokines in the inhibition of glucose output
To determine which of the cytokines are important in the development of the response, different combinations were employed and the effects on glucose production and NO # − jNO $ − output measured (Table 3) . With the exception of IL-1β, none of the other cytokines had any significant effect on NO production measured over the 24 h incubation period. Similarly, combinations of any two cytokines only stimulated NO # − jNO $ − output when IL-1β was one of the components. LPS had no significant additive effect when added with any combination of cytokines, and the combination IFN-γjIL-1βjTNF-α resulted in a stimulation of NO # − jNO $ − output comparable with that with the three cytokines plus LPS (8-fold stimulation). The presence of IFN-γ enhanced the response to the other cytokines, and it synergized with both IL-1β and TNF-α in all combinations. This is clearly shown by the combination of TNF-αjIL-1βjLPS, which gave a much smaller effect (3-fold stimulation) than the complete mixture. Although TNF-α had no significant effect alone, it became significant when added in the presence of IFN-γ and was required for the generation of a maximal response over this time course, as judged by a comparison of the effect of IFN-γjIL-1βjLPS and the response in the presence of all the factors (5.6-fold response compared with an 8-fold response). Other combinations which resulted in 3-4-fold increases in NO production all had IL-1β as a common factor, which synergized with both IFN-γ and TNF-α. These findings are comparable with those of Curran et al. [14] using a similar experimental system.
As shown above, the complete cytokine mixture plus LPS significantly inhibited glucose release by the cells (40 %). Similarly, culturing the cells with the combinations IFN-γjIL-1βjTNF-α or IFN-γjIL-1βjLPS also resulted in significant inhibition of glucose production (20-25 %). The presence of IFN-γ was essential for the inhibitory effect on glucose output to be observed, the combination of TNF-αjIL-1βjLPS being unable to elicit any significant inhibition. In general those treatments that resulted in high levels of NO production inhibited glucose synthesis, whereas combinations of cytokines which increased NO # − jNO $ − production to a lesser extent had no significant effect on glucose metabolism. This suggests that, if NO is the sole mediator, there must be a threshold rate of NO production or a cumulative effect which is required before the inhibition of glucose production becomes apparent. A similar situation has been shown to exist during the cytokine-induced inhibition of protein synthesis in cultured hepatocytes [14] . However, the correlation with NO production does not appear to hold for cells treated with TNF-αjIFN-γ, where a significant inhibition of glucose output occurred (30 %) in the presence of only a 2-fold increase in NO production. Similarly, although both the cytokine mixture plus LPS and IFN-γjIL-1βjTNF-α inhibited glucose release, the complete mixture was significantly (P 0.01) more inhibitory than the three cytokines alone, suggesting an additional role for LPS in the inhibition of glucose release. This contrasts with the induction of NO synthase and suggests the involvement of non-NO-mediated mechanisms in the inhibition of glucose production by cytokines plus LPS.
Time courses of the effects of different cytokine mixtures on glucose output and NO production
Although the above results suggest that low concentrations of NO are insufficient to inhibit glucose output and that other mechanisms may be involved in the cytokine-mediated inhibition of glucose synthesis, because NO # − jNO $ − production was measured over the entire 24 h treatment period and the NOmediated inhibition of glucose synthesis is reversible [16] , the possibility that NO may be involved is not precluded. It is possible that the different cytokine combinations may induce NO with different time courses and that both NO production and the inhibition of glucose synthesis may not be sustained over the entire 24 h time course. Therefore the time courses for the effects of different selected cytokine combinations on both glucose output and NO production were measured (Table 4 ). For none of the combinations examined was there any significant effect at 3 h on either parameter. The presence of the complete cytokine mixture resulted in a linear production of NO # − jNO $ − between 6 and 24 h, suggesting that NO synthase was maximally induced within the 3-6 h time period and that this level of induction was sustained throughout the 24 h incubation period. This time of onset of induction is similar to that observed in the livers of intact animals following LPS treatment, although the response was maintained for longer in the cultured cells [15, 17] . The inhibition of glucose synthesis did not correlate with the early rise in NO # − jNO $ − , but there was a progressive decline over the treatment period which only became significant following 9 h of exposure to the complete cytokine mixture. This suggests that, if NO is the sole mediator, then the cells require prolonged exposure to NO for the effect on glucose production to become apparent. This does not correlate with the acute effects of NO donors [16] , although it could be argued that this is the result of the relative concentrations of NO the cells are exposed to in the two situations.
The combination of TNF-αjIL-1βjLPS produced a change in NO synthase activity equivalent to 75 % of that due to the complete mixture up to 9 h ; however, after this time there was no significant change in NO production, suggesting only a transient stimulation of NO synthase expression in the absence of IFN-γ. There was no effect of this treatment regimen on glucose release at any time point, which could only be explained in terms of NO if the inhibition requires a prolonged exposure to NO and NO production had ceased by the time the measurements of glucose synthesis were performed. Treatment of the cells with IFNγjIL-1βjLPS resulted in a change in NO synthase activity comparable with that induced by the entire mixture up to 9 h ; however, there was some decline in activity between 9 and 24 h. Glucose output was significantly inhibited at the 9 and 24 h time points, although to a lesser extent than with the complete cytokine mixture. TNF-α, alone or in combination with LPS, had no significant effect on glucose production or NO synthesis over the entire incubation period, indicating that the presence of IL-1β or IFN-γ is required for the response under the culture conditions used. The inability of either TNF-α or IL-1β to inhibit glucose release agrees with the data of Blumberg et al. [26] ; however, it contrasts with the work of Goto et al. [27] and Dahn et al. [28] , which suggested that TNF-α alone can lead to an acute inhibition of glucose synthesis in hepatocytes. Following treatment of the cells with TNF-αjIFN-γ a significant increase in NO # − jNO $ − production was only observed between 9 and 24 h, suggesting a long delay in the induction of the enzyme by this combination of cytokines, with an effect probably only in the last few hours. Although the increase in NO # − jNO $ − occurred at the same time as the inhibition of glucose production, the concentration of NO produced was less than that produced by TNFαjIL-1βjLPS, which failed to cause a decrease in glucose output. Again, this would argue against the requirement for a cumulative effect of NO over an extended period, further supporting the argument for an NO-independent inhibition of glucose release.
Effect of L-NMMA on the cytokine-induced inhibition of glucose output
The above results suggest that NO is not the major mechanism underlying the inhibition of glucose synthesis by this combination of cytokines. The most compelling evidence for the involvement of NO in this response was the finding that -NMMA, a competitive inhibitor of NO synthase, blocked the effect of the cytokines on glucagon-stimulated glucose production in the study of Stadler et al. [19] . The effect of incubating the cells with 1.0 mM -NMMA was therefore examined ( Table 5 ). As shown above, the complete cytokine mixture increased NO synthase activity and inhibited glucose output by the cells. Addition of -NMMA to the control cells resulted in a small but significant increase in glucose production and also resulted in a 2-fold increase in NO # − jNO $ − production. In the presence of the cytokines the increase in NO # − jNO $ − was completely abolished by the presence of the inhibitor. Glucose output was also significantly enhanced by the inhibitor in the presence of the cytokine mixture ; however, the difference between the control and cytokine-treated cells was maintained, indicating that abolishing the production of NO did not prevent the inhibitory effect of the cytokines. Table 5 also shows that similar results were evident when other cytokine combinations were employed and, although 1.0 mM -NMMA increased glucose production, it did so in both the control and cytokine-treated cells such that the difference was maintained, despite the inhibitory effect on NO # − jNO $ − production. The reason for the discrepancy between the results presented here and those of Stadler et al. [19] remains to be established. The major differences between the two studies were the nutritional state of the animal from which the cells were derived and the continuous presence of a high concentration of insulin in the culture medium of Stadler et al. [19] . This would lead to a much lower rate of gluconeogenesis due to the loss of phosphoenolpyruvate carboxykinase activity from the cells and also to a lower rate of glycogenolysis. This may explain why no significant effects of the cytokines were evident on the basal rate of glucose output (in contrast to the present study), the effect only being apparent following short-term stimulation with glucagon. Under the conditions employed by Stadler et al. [19] , glycogenolysis would make a much greater contribution to total glucose output in the presence of glucagon, and the observation that NO produced from artificial donors is capable of inhibiting the rate of glucagon-stimulated glycogenolysis, but not the basal rate, in isolated hepatocytes may be very pertinent to this question [29] .
Conclusions
From the present data it is evident that treatment of hepatocytes with LPS plus a mixture of cytokines known to be produced during endotoxic shock results in increased expression of inducible NO synthase and inhibition of glucose release from the cells. The substrate specificity of the gluconeogenic response and the time courses for both the inhibition of glucose production and the induction of NO synthase are comparable with those observed in i o following endotoxin treatment of the rat, indicating that these mediators may be responsible for the inhibition of gluconeogenesis during endotoxic shock. Although it is evident that NO derived from artificial donors is capable of inhibiting gluconeogenesis [16] , and the work of Stadler et al. [19] has implicated NO as the mediator of the cytokine-induced inhibition of glucose synthesis, the present work does not support this concept. The pattern of inhibition of glucose synthesis with the different cytokine mixtures does not correlate well with the release of NO ; similarly, the inability of -NMMA to inhibit the response to the different cytokine mixtures employed suggests that this is not the major mechanism by which glucose production is inhibited and that the induction of NO synthase is a parallel event. This does not preclude the possibility that NO may still be involved in the alterations of glucose homoeostasis in i o, as it is evident from studies with rat islets that different cytokine treatment regimens may produce both NO-dependent and -independent effects depending upon the time of exposure to the cytokines and the concentrations used [30] .
